INTS
USDIntensity Therapeutics Inc. Common stock
$0.566-0.084 (-12.954%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Key Metrics
Market Metrics
Open
$0.650
High
$0.650
Low
$0.550
Volume
0.00M
Company Fundamentals
Market Cap
13.7M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.10M
Exchange
NCM
Currency
USD
52-Week Range
Low $0.55Current $0.566High $5.275
Related News
PR Newswire
Intensity Therapeutics Reports 2024 Year End Financial Results and Provides Corporate Update
Intensity Therapeutics, Inc. ("Intensity" or "the Company") (Nasdaq: INTS), a late-stage clinical biotechnology company focused on the discovery and...
View more
Related Stocks
ACGL
Arch Capital Group Ltd.
NASDAQ
Property-Casual...
ONCT
Oncternal Therapeutics Inc.
NASDAQ
Biotechnology: ...
RCB
Ready Capital Corporation 6.20% Senior Notes due 2026
NASDAQ
Real Estate Inv...
BHACW
Focus Impact BH3 Acquisition Company Warrants
NASDAQ
Blank Checks
FCEL
FuelCell Energy Inc.
NASDAQ
Industrial Mach...
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.